Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Multicenter Controlled Clinical Trial to Evaluate Safety and Efficacy of Aerosolized MIR 19 ® Inhalation in Adult Outpatients With Mild COVID-19.

NCT05783206 is registered in ClinicalTrials.gov with National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia as lead sponsor.

NCT NCT05783206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05783206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Multicenter Controlled Clinical Trial to Evaluate Safety and Efficacy of Aerosolized MIR 19 ® Inhalation in Adult Outpatients With Mild COVID-19.
Lead sponsor
National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
Phase
Phase 2/3
Overall status
Completed
Start date
February 10, 2022
Completion date
July 28, 2023
Enrollment
984 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19